Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hainan Shennong Seed Industry Technology
300189
5
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 9.510
- -1.060-10.03%
Close Apr 7 16:00 ET
- 9.530
- +0.020+0.21%
Post 16:24 ET
518.52MMarket Cap-7.61P/E (TTM)
10.560High9.021Low487.78KVolume10.240Open10.570Pre Close4.68MTurnover1.73%Turnover RatioLossP/E (Static)54.52MShares28.09052wk High1.05P/B268.80MFloat Cap9.02152wk Low--Dividend TTM28.26MShs Float28.090Historical High--Div YieldTTM14.56%Amplitude9.021Historical Low9.596Avg Price1Lot Size
About Bicara Therapeutics Company
Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and it developing first-in-class biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, is a first-in-class EGFR/TGF-?-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.
Company Profile
SymbolBCAX
Company NameBicara Therapeutics
Listing DateSep 13, 2024
Issue Price18.00
Founded2018
CEODr. Claire Mazumdar, PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address116 Huntington Avenue,Suite 703
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-617-468-4219
Websitehttp://www.bicara.com
Company Executives
- Name
- Position
- Salary
- Dr. Claire Mazumdar, PhD
- Chief Executive Officer and Director
- 4.54M
- Lara Meisner
- Chief Legal Officer
- --
- Dr. David Raben, M.D.
- Chief Medical Officer
- --
- Ryan Cohlhepp
- President and Chief Operating Officer
- 3.16M
- Ivan Hyep
- Chief Financial Officer and Principal Accounting Officer
- 2.48M
- Dr. Michael F. Powell, PhD
- Chairman of the Board
- --
- Kiran Mazumdar-Shaw
- Director
- --
- Dr. Vijay Kumar Kuchroo
- Independent Director
- 150.66K
- Dr. Heath Lukatch, PhD
- Independent Director
- --
- Kate Haviland
- Independent Director
- 175.90K
- Scott Robertson, M.B.A.
- Independent Director
- --
- Dr. Nils Lonberg, PhD
- Independent Director
- 150.66K
- Dr. Jake Sin, PhD
- Independent Director
- --
- Dr. Christopher Bowden, M.D.
- Independent Director
- --
- Dr. Carolyn Ng, PhD
- Independent Director
- --
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now